Adicet Bio (ACET) Change in Account Payables (2017 - 2026)

Adicet Bio's Change in Account Payables history runs 10 years deep, the most recent figure standing at -$1.8 million for Q1 2026.

• In Q1 2026, Change in Account Payables fell 386.17% year-over-year to -$1.8 million; the TTM figure through Mar 2026 stood at -$1.4 million (down 172.05% YoY), while the FY2025 annual figure was $1.0 million, down 6.96% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$1.8 million, down from $307000.0 in the prior quarter.
• The five-year high for Change in Account Payables was $1.7 million in Q3 2022, with the low at -$2.3 million in Q1 2023.
• The 5-year median for Change in Account Payables is $307000.0 (2025), against an average of $21294.1.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables sank 412.24% in 2022, then soared 402.4% in 2025.
• Adicet Bio's Change in Account Payables stood at $1.2 million in 2022, then plunged by 226.52% to -$1.5 million in 2023, then jumped by 178.97% to $1.2 million in 2024, then slumped by 73.37% to $307000.0 in 2025, then tumbled by 686.32% to -$1.8 million in 2026.
• Business Quant data shows ACET's Change in Account Payables at -$1.8 million in Q1 2026, $307000.0 in Q4 2025, and $1.2 million in Q3 2025.